- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7056 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
Patent holdings for IPC class A61K 31/7056
Total number of patents in this class: 1224
10-year publication summary
|
110
|
112
|
95
|
102
|
94
|
138
|
96
|
85
|
68
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 1951 |
43 |
| Galecto Biotech AB | 84 |
41 |
| Boehringer Ingelheim Vetmedica GmbH | 1289 |
30 |
| Takeda Pharmaceutical Company Limited | 2943 |
19 |
| Kissei Pharmaceutical Co., Ltd. | 198 |
19 |
| Centre National de La Recherche Scientifique | 10102 |
17 |
| Vertex Pharmaceuticals Incorporated | 1568 |
16 |
| Boehringer Ingelheim International GmbH | 4754 |
15 |
| GlycoMimetics, Inc. | 133 |
15 |
| Bausch Health Ireland Limited | 773 |
14 |
| Bristol-myers Squibb Company | 4863 |
13 |
| President and Fellows of Harvard College | 5913 |
12 |
| Novartis AG | 11254 |
11 |
| Merck Sharp & Dohme Corp. | 2219 |
9 |
| Alectos Therapeutics Inc. | 49 |
9 |
| Cmpd Licensing, LLC | 72 |
8 |
| Enanta Pharmaceuticals, Inc. | 422 |
8 |
| Idenix Pharmaceuticals LLC | 64 |
8 |
| Merck Sharp & Dohme LLC | 3751 |
8 |
| Pfizer Inc. | 3368 |
7 |
| Other owners | 902 |